JAN 30, 2016 6:38 AM PST

New System Effective At Testing Anticoagulants

WRITTEN BY: Kara Marker
Anticoagulant drugs thin the blood (I.E. “blood thinners”) to prevent dangerous clotting in the vessels. People take anticoagulants for a variety of reasons:
  • Prevent economy-class syndrome after knee or hip joint surgeries, a form of deep vein thrombosis named after the risk of developing this disorder after sitting on a plane too long
  • Coronary artery disease
  • Atrial fibrillation
Finding the right balance of medication is extremely important, because the blood needs to be able to clot to protect the body from excessive internal or external bleeding. A new type of anticoagulant, called novel oral anti-coagulants (NOACs), are some of the most effective blood thinners of the last decade. They can usually be used safely with other drugs, and patients taking NOACs do not have to change their diet.
 
The only problem that arises with using NOACs is understanding how their abilities affect different patients. Although they are highly effective, the lack of a technology to accurately determine their effect made it difficult for doctors to recommend an addition or switch with NOACs to their patients already taking anticoagulants.
 
A new system has alleviated this problem: the total thrombus-formation analysis system (T-TAS) developed by a Japanese company called Fujimori Kogyo Co., Ltd. T-TAS is uniquely able to test thrombus (blood clot) formation “under various blood flow conditions.” Plus, it only needs a small amount of whole blood for each test.
 
T-TAS

 
Killing two birds with one stone, researchers from Kumamoto University in Japan tested both the efficacy of the new system and the blood clotting risks of NOAC drugs. They looked at patients from three different cohorts, taking NOACs for various reasons. T-TAS proved to be extremely useful for determining the amount and variety of anticoagulants certain patients should take in certain situations (pre-surgery, post-surgery, etc.).
 
"With the help of T-TAS data, we were able to prevent future thrombotic and hemorrhagic complications,” said research leader Dr. Kaikita of Kumamoto University. The Kumamoto study was published in the International Journal of Cardiology.
 
Further use of T-TAS will help doctors provide patients with the perfect concoction of anticoagulants, making individualized medicine all the more accessible and easy.
 

Source: Kumamota University
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 02, 2021
Cardiology
Creating a Light Switch in the Heart to Regulate Heart Rate
MAR 02, 2021
Creating a Light Switch in the Heart to Regulate Heart Rate
Often when it is dark, we go for a flashlight or our phone to see where we are going. What if I told you that is much th ...
MAR 01, 2021
Cardiology
How Heart Problems May Lead to Memory Deficits
MAR 01, 2021
How Heart Problems May Lead to Memory Deficits
Researchers have used a mouse model to show that heart problems can lead to disruptions in gene activity in the memory c ...
MAY 04, 2021
Cardiology
Does Sleep Apnea Affect Blood Pressure During REM Sleep?
MAY 04, 2021
Does Sleep Apnea Affect Blood Pressure During REM Sleep?
Sleep is a time for your body to rest and recover from the day. Your heart slows down, and your breathing relaxes.   ...
JUN 24, 2021
Technology
New Hydrogel Designed to Prevent Post-surgical Heart Tissue Adhesions
JUN 24, 2021
New Hydrogel Designed to Prevent Post-surgical Heart Tissue Adhesions
Nearly 20% of cardiac surgery patients will require another operation at some point in the future. This is especially tr ...
SEP 02, 2021
Cancer
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
SEP 02, 2021
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
High cholesterol is associated with an increased risk of several types of cancer, and cancer patients with high choleste ...
SEP 01, 2021
Clinical & Molecular DX
Will Childhood Cancer Survivors Go On to Have Broken Hearts?
SEP 01, 2021
Will Childhood Cancer Survivors Go On to Have Broken Hearts?
Patients are seven times more likely to have a heart attack or stroke than the general population after receiving treatm ...
Loading Comments...